SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (3429)10/23/2003 12:31:25 AM
From: Gulo  Read Replies (1) | Respond to of 23958
 
Re DSCO
Sounds to me like the "powerful medications to make one last effort to reduce the inflammation in Dalton's lungs" was not a surfactant. ARDS might be helped by inhaling a particular surfactant but that doesn't mean its role is to fight inflammation. More likely, the drug mentioned was a steroid or other anti-inflammatory. I wouldn't assume that reference has anything to do with DSCO or Surfaxin.
-g


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News